Table 4. Overall best response summary (RECIST): intent-to-treat population.
|
Initial dose level (olaparib mg bd per DTIC mg m−2)
|
||||||||
|---|---|---|---|---|---|---|---|---|
| Overall best response, n (%) | 10/600 (n=3) | 20/600 (n=4) | 20/800 (n=4) | 40/600 (n=4) | 40/800 (n=6) | 100/600 (n=13) | 200/600 (n=6) | Total (n=40) |
| Partial response | 0 | 0 | 0 | 1 (25.0) | 0 | 0 | 1 (16.7) | 2 (5.0) |
| Progressive disease | 3 (100) | 3 (75.0) | 4 (100) | 3 (75.0) | 5 (80.0) | 9 (69.2) | 3 (50.0) | 30 (75.0) |
| Stable disease | 0 | 1 (25) | 0 | 0 | 1 (20.0) | 4 (30.8) | 2 (33.3) | 8 (20.0) |
Abbreviation: RECIST=response evaluation criteria in solid tumors.